S.A

Opinion of the Board of Directors regarding the Possible Voluntary Tender Offer for Bachoco's shares

Retrieved on: 
Wednesday, September 28, 2022

In this regard, the Board, taking into account its analysis, considered that the proposed price in the potential offer is fair, from a financial point of view, for the Company's shareholders.

Key Points: 
  • In this regard, the Board, taking into account its analysis, considered that the proposed price in the potential offer is fair, from a financial point of view, for the Company's shareholders.
  • Industrias Bachoco is a leader in the poultry industry in Mexico and one of the largest poultry companies in the world.
  • The document contains information that could be deemed forward-looking statements regarding expected future events and results of the Company.
  • This press release is not an offer to sell securities in the United States, Mexico, or elsewhere.

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

Retrieved on: 
Wednesday, September 28, 2022

NASHVILLE, Tenn. and MENDRISIO, Switzerland, September 28, 2022 /PRNewswire/ -- Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, and Sintetica, S.A., a growing pharmaceutical company focused on analgesics, local anesthetics, and sterile injectable solutions, today jointly announced the U.S. Food and Drug Administration (FDA) approval of IHEEZO™ (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia. IHEEZO is a sterile, single-patient-use, physician-administered, ophthalmic gel preparation, containing no preservatives, that is safe and effective for ocular surface anesthesia. IHEEZO represents the first approved use in the U.S. ophthalmic market of chloroprocaine hydrochloride and the first branded ocular anesthetic approved for the U.S. ophthalmic market in nearly 14 years. IHEEZO is protected by an Orange Book-listed patent that is valid until 2038.

Key Points: 
  • IHEEZORepresentstheFirstApproved UseintheU.S.OphthalmicMarket of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14 Years
    IHEEZO was Licensed by Harrow for the U.S. and Canadian Markets From100-Year-OldInternationalPharmaceuticalCompanySintetica,S.A.
  • IHEEZO represents the first approved use in the U.S. ophthalmicmarketof chloroprocaine hydrochloride and the first branded ocular anesthetic approved for the U.S. ophthalmic market in nearly 14 years.
  • IHEEZO is protected by an Orange Book-listed patent that is valid until 2038.
  • Iwanttogivespecial thankstoourregulatorygroup, who while working with the Harrow team, performed extraordinarily well, resulting in this early U.S. market approval for this important new medicine."

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

Retrieved on: 
Wednesday, September 28, 2022

NASHVILLE, Tenn. and MENDRISIO, Switzerland, September 28, 2022 /PRNewswire/ -- Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, and Sintetica, S.A., a growing pharmaceutical company focused on analgesics, local anesthetics, and sterile injectable solutions, today jointly announced the U.S. Food and Drug Administration (FDA) approval of IHEEZO™ (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia. IHEEZO is a sterile, single-patient-use, physician-administered, ophthalmic gel preparation, containing no preservatives, that is safe and effective for ocular surface anesthesia. IHEEZO represents the first approved use in the U.S. ophthalmic market of chloroprocaine hydrochloride and the first branded ocular anesthetic approved for the U.S. ophthalmic market in nearly 14 years. IHEEZO is protected by an Orange Book-listed patent that is valid until 2038.

Key Points: 
  • NASHVILLE, Tenn. and MENDRISIO, Switzerland, September 28, 2022 /PRNewswire/ -- Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, and Sintetica, S.A., a growing pharmaceutical companyfocused onanalgesics,localanesthetics,andsterileinjectablesolutions,todayjointly announced the U.S. Food and Drug Administration (FDA) approval of IHEEZO (chloroprocaine hydrochloride ophthalmicgel)3%forocularsurface anesthesia.IHEEZOisasterile, single-patient-use, physician-administered,ophthalmicgelpreparation,containingnopreservatives,thatissafeandeffective for ocular surface anesthesia.
  • IHEEZO represents the first approved use in the U.S. ophthalmicmarketof chloroprocaine hydrochloride and the first branded ocular anesthetic approved for the U.S. ophthalmic market in nearly 14 years.
  • IHEEZO is protected by an Orange Book-listed patent that is valid until 2038.
  • Iwanttogivespecial thankstoourregulatorygroup, who while working with the Harrow team, performed extraordinarily well, resulting in this early U.S. market approval for this important new medicine."

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

Retrieved on: 
Tuesday, September 27, 2022

IHEEZO is a sterile, single-patientuse, physicianadministered, ophthalmic gel preparation, containing no preservatives, that is safe and effective for ocular surface anesthesia.

Key Points: 
  • IHEEZO is a sterile, single-patientuse, physicianadministered, ophthalmic gel preparation, containing no preservatives, that is safe and effective for ocular surface anesthesia.
  • IHEEZO represents the first approved use in the U.S. ophthalmic market of chloroprocaine hydrochloride and the first branded ocular anesthetic approved for the U.S. ophthalmic market in nearly 14 years.
  • Study 3 marks the first time a U.S. drug candidate was studied in a surgical model for FDA approval in the ocular surface anesthesia category.
  • Baum continued, Harrow currently provides perioperative medications for a significant number of the U.S. ophthalmic surgical procedures.

Global Compute, Southern Cross Group team up with Data Horizon Americas to launch new Latin America-focused datacenter platform; acquires 12-acre parcel in Bogota, Colombia expected to deliver 55 MWs of total datacenter power capacity upon completion

Retrieved on: 
Monday, September 26, 2022

SCG is the first and longest-standing large-cap, exclusively Latin America-dedicated pan-regional private equity investment fund with more than 20 years of history.

Key Points: 
  • SCG is the first and longest-standing large-cap, exclusively Latin America-dedicated pan-regional private equity investment fund with more than 20 years of history.
  • DHA is also announcing today its first campus launch, located in the Bogota Metropolitan Region, Colombia.
  • The campus is proximate to all major peering exchange points and can deliver initial capacity as early as 1H24.
  • The Southern Cross team is comprised of ten principals, located in six regional offices, and has recently completed the deployment of its fifth Fund.

AM Best Revises Outlooks to Positive and Affirms Credit Ratings of BUPA México, Compañía de Seguros, S.A. de C.V.

Retrieved on: 
Friday, September 23, 2022

The Credit Ratings (ratings) reflect Bupa Mexicos balance sheet strength, which AM Best assesses as weak, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.

Key Points: 
  • The Credit Ratings (ratings) reflect Bupa Mexicos balance sheet strength, which AM Best assesses as weak, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.
  • Bupa Mexico is a subsidiary of Bupa Insurance Company (BIC), and is tied to the groups commercial strategy of expanding into Mexicos insurance market, leveraging on the Bupa brand.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

Volante Technologies Named to Prestigious IDC FinTech Rankings Top 100 for Second Year Running

Retrieved on: 
Thursday, September 22, 2022

LONDON, Sept. 22, 2022 /PRNewswire/ -- Volante Technologies, the global leader in cloud payments and financial messaging, today announced that it has been named to The IDC FinTech Rankings Top 100 for the second year in a row. The IDC FinTech Rankings 2022 evaluates and categorizes the top IT vendors based on 2021 calendar year revenues and the percentage of revenues exclusively attributed to financial institutions.

Key Points: 
  • LONDON, Sept. 22, 2022 /PRNewswire/ -- Volante Technologies , the global leader in cloud payments and financial messaging, today announced that it has been named to The IDC FinTech Rankings Top 100 for the second year in a row.
  • According toAaron Press, Research Director at IDC Financial Insights, "Volante's focus on payments has once again placed the company on the IDC Fintech Rankings Top 100.
  • The IDC Fintech Rankings, now in its 19th year, is the global standard list of fintech providers to the industry, and we congratulate Volante for their placement among the 2022 winners."
  • For more information about the The IDC FinTech Rankings 2022, visit http://www.idc-fi.com and follow on Twitter @IDC and look for #IDCFinTechRankings.

Volante Technologies Named to Prestigious IDC FinTech Rankings Top 100 for Second Year Running

Retrieved on: 
Thursday, September 22, 2022

LONDON, Sept. 22, 2022 /PRNewswire/ -- Volante Technologies, the global leader in cloud payments and financial messaging, today announced that it has been named to The IDC FinTech Rankings Top 100 for the second year in a row. The IDC FinTech Rankings 2022 evaluates and categorizes the top IT vendors based on 2021 calendar year revenues and the percentage of revenues exclusively attributed to financial institutions.

Key Points: 
  • LONDON, Sept. 22, 2022 /PRNewswire/ -- Volante Technologies , the global leader in cloud payments and financial messaging, today announced that it has been named to The IDC FinTech Rankings Top 100 for the second year in a row.
  • According toAaron Press, Research Director at IDC Financial Insights, "Volante's focus on payments has once again placed the company on the IDC Fintech Rankings Top 100.
  • The IDC Fintech Rankings, now in its 19th year, is the global standard list of fintech providers to the industry, and we congratulate Volante for their placement among the 2022 winners."
  • For more information about the The IDC FinTech Rankings 2022, visit http://www.idc-fi.com and follow on Twitter @IDC and look for #IDCFinTechRankings.

GigNet Announces Agreement to Provide High-Speed Broadband to Caribbean College Cancun

Retrieved on: 
Wednesday, September 21, 2022

GigNet, a Digital Infrastructure company with an extensive regional fiber optic broadband network from Costa Mujeres, North of Cancun, through the Hotel Zone of Tulum, announced today it is providing advanced broadband for high-speed Internet to Caribbean College, a privately-operated educational institution in Cancun, Mexico.

Key Points: 
  • GigNet, a Digital Infrastructure company with an extensive regional fiber optic broadband network from Costa Mujeres, North of Cancun, through the Hotel Zone of Tulum, announced today it is providing advanced broadband for high-speed Internet to Caribbean College, a privately-operated educational institution in Cancun, Mexico.
  • Ms. Patricia Gonzalez, Director of Caribbean College, said, I am grateful we are connected to the GigNet network.
  • This has given us the possibility to expand our academic curriculum since teachers in the classroom require a powerful and effective Internet connection.
  • High-speed broadband is an absolute requirement for students of all ages, from Kindergarten through higher education, and GigNet is immensely proud to enable the teachers and staff of Caribbean College to connect these young students to educational resources from around the world.

Dah Sing Bank and Friends of the Earth (HK) Jointly Present Retail and E-Commerce ESG Forum for SMEs

Retrieved on: 
Wednesday, September 21, 2022

HONG KONG, Sept 21, 2022 - (ACN Newswire) - The second industry forum (the "Forum") under the SME ESG Best Practices Recognition Programme ("the Programme") took place today under the joint auspices of Dah Sing Bank, Limited ("Dah Sing Bank") and Friends of the Earth (HK) ("FoE HK").

Key Points: 
  • HONG KONG, Sept 21, 2022 - (ACN Newswire) - The second industry forum (the "Forum") under the SME ESG Best Practices Recognition Programme ("the Programme") took place today under the joint auspices of Dah Sing Bank, Limited ("Dah Sing Bank") and Friends of the Earth (HK) ("FoE HK").
  • Dah Sing Bank, Limited ("Dah Sing Bank") is a wholly-owned subsidiary of Dah Sing Banking Group Limited (HKG:2356) which is listed on the Hong Kong Stock Exchange.
  • In addition to its Hong Kong banking operations, Dah Sing Bank also has wholly-owned subsidiaries including Dah Sing Bank (China) Limited, Banco Comercial de Macau, S.A., and OK Finance Limited.
  • Dah Sing Bank and Friends of the Earth (HK) Jointly Present:
    Industry Forums / Programme Application Opens: 27 June 2022 / 21 September 2022
    Online Questionnaire Completion & Supporting Documents Submission: Until 31 December 2022 / Until 28 February 2023